Omid started as an electrical engineer and is now CEO of Ascendant Dx, a proteomics company focused on bringing new diagnostic tests to market. Currently they are focusing on tests based on newly discovered biomarkers for breast cancer and childhood diseases. Omid is an experienced executive, entrepreneur and inventor. He has spent the last 18 years bringing new products and businesses to market in fields ranging from photography, medical imaging, and microprocessors to graphics, healthcare information technology and genomics. He specializes in finding markets for new technologies, or finding new markets for old technologies. Specially, if it involves developing new business models, and new corporate structures. He is also an expert in intellectual property strategy development. Omid is Entrepreneur In Residence at University of California at Los Angeles and has done Personal Genomics Research at Harvard Medical School http://www.ascendantdx.com/ Jon Cadieux Managing Director 455 Media Group, LLCwww.455mediagroup.com Jeff AmerineFounding PrincipleStartup Junkie Consultingwww.startupjunkieconsulting.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related